2Straub M,Hautmann RE.Developments in stone prevention[J].Current Opinion in Urology,2005,15 (2):119.
3Resnick MI,Sorrell ME,Bailey JA,et al.Inhibitory effects of urinary calcium-binding substances on calcium oxalate crystal-lization[J].The Journal of Urology,1982,127 (3):568.
4Schurink CA,Hoitsma M,Rozenberg-Arska M,et al.Do cultures contribute to optimisation of antibiotic therapy in the intensive care unit[J] ? Int J Antimicrob Agents,2004,23(4):325-331.
5Shaochuang Wang,Hui Liu,Lifeng Ren,et al.Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference[J].Neoplasia,2008,10:399-407.
6Hateh M,Freel RW.Intestinal transport of an obdurate anion:oxalate[J].Urol Res,2005,33 (1):1-16.
7Hateh M,Freel RW.The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis[J].Semin Nephrol,2008,28 (2):143-151.
8Goodman HO,Brommage R,Assimos DG,et al.Genes in idiopathic calcium oxalate stone disease[J].World J Urol,1997,15 (3):186-194.
9Prenen JA,Boer P,Dorhout Mees EJ.Absorption kinetics of oxalate from oxalate-rich food in man[J].Am J Clin Nutr,1984,40:1007-1010.
10Lindsjo M,Danielaon BG,Fellstrom B.Intestinal ozalate and calcium absorption in recurrent renal stone formers and healthy subjects[J].Scand J Urol Nephrol,1989,23:55-59.
二级参考文献21
1Gogvadze V, Orrenius S, Zhivotovsky, B. Multiple pathways of cytochrome c release from mitochondria in apoptosis [ J]. Biochimica et Biaphysica Acta , 2006,1757 (5 -6) :639 - 647.
2Miyazawa K, Suzuki K, Ikeda R. Apoptosis and its related genes in renal epithelial cells of the stone - forming rat [ J ]. Urol Res, 2005, 33(1) :31 -38.
3Meimaridou E, Lobos E, Hothersall JS. Renal oxidative vulnerability due to changes in mitochondrial - glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasi[J]. Am J Physiol Renal Physiol , 2006, 291(4):731 -740.
4Jeong BC, Kwak C, Cho KS. Apoptosis induced by oxalate in human renal tubular epithelial HK -2 cells [J]. Urol Res, 2005,33(2) :87 -92.
5Jonassen JA, Cao LC, Honeyman T. Intracellular Events in the Initiation of Calcium Oxalate Stones [ J ]. Nephron Exp Nephrol, 2004, 98(2) :e61 -64.
6Asselman M, Verkoelen CF. Crystal - cell interaction in the pathogenesis of kidney stone disease [ J ]. Curr Opin Urol, 2002, 12 (4) :271 - 276.
7Veena CK, Josephine A, et al. Mitochondrial dysfunction in an animal model of hyperoxaluria:A prophylactic approach with fucoidan [J]. Ear J Pharmacol, 2008 ,579( 1 -3) :330 -6.
9Clarke SJ , McStay GP , Halestrap AP. Sanglifehrin A acts as a potent inhibitor of the mitoehondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin - D at a different site from cyclosporin A[J]. Biol Chem ,2002 ,277 (38) :34793 -34799.
10[1]Gsur A,Madersbacher S,Haldinger G,et al.Vitamin D receptor gene polymorphiSm and prostate cancer risk.Prostate,2002;51(1):30～34
